vs
LXP Industrial Trust（LXP）与PTC THERAPEUTICS, INC.（PTCT）财务数据对比。点击上方公司名可切换其他公司
PTC THERAPEUTICS, INC.的季度营收约是LXP Industrial Trust的1.9倍（$164.7M vs $86.7M），LXP Industrial Trust净利率更高（33.2% vs -82.0%，领先115.1%），LXP Industrial Trust同比增速更快（-14.0% vs -22.7%），过去两年LXP Industrial Trust的营收复合增速更高（0.3% vs -11.5%）
LXP工业信托是一家公开上市的房地产投资信托，专注于持有、运营和投资美国核心市场的优质工业地产，主要涵盖配送中心、物流设施及轻型工业物业，服务电商、第三方物流、先进制造等领域租户，为投资者创造长期稳定收益。
PTC Therapeutics是一家总部位于美国的制药企业，专注于开发口服小分子药物及基因疗法，通过靶向转录后调控机制调节基因表达，相关产品管线主要面向罕见病治疗领域，致力于满足相关疾病未被覆盖的临床治疗需求。
LXP vs PTCT — 直观对比
营收规模更大
PTCT
是对方的1.9倍
$86.7M
营收增速更快
LXP
高出8.8%
-22.7%
净利率更高
LXP
高出115.1%
-82.0%
两年增速更快
LXP
近两年复合增速
-11.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $86.7M | $164.7M |
| 净利润 | $28.8M | $-135.0M |
| 毛利率 | 81.5% | — |
| 营业利润率 | 34.6% | -43.3% |
| 净利率 | 33.2% | -82.0% |
| 营收同比 | -14.0% | -22.7% |
| 净利润同比 | — | -104.8% |
| 每股收益（稀释后） | — | $-1.63 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LXPPTCT
| Q4 25 | $86.7M | $164.7M | ||
| Q3 25 | $86.9M | $211.0M | ||
| Q2 25 | $87.7M | $178.9M | ||
| Q1 25 | $88.9M | $1.2B | ||
| Q4 24 | $100.9M | $213.2M | ||
| Q3 24 | $85.6M | $196.8M | ||
| Q2 24 | $85.8M | $186.7M | ||
| Q1 24 | $86.3M | $210.1M |
净利润LXPPTCT
| Q4 25 | $28.8M | $-135.0M | ||
| Q3 25 | $36.3M | $15.9M | ||
| Q2 25 | $29.1M | $-64.8M | ||
| Q1 25 | $19.0M | $866.6M | ||
| Q4 24 | — | $-65.9M | ||
| Q3 24 | $6.3M | $-106.7M | ||
| Q2 24 | $5.4M | $-99.2M | ||
| Q1 24 | $-269.0K | $-91.6M |
毛利率LXPPTCT
| Q4 25 | 81.5% | — | ||
| Q3 25 | 82.3% | — | ||
| Q2 25 | 81.9% | — | ||
| Q1 25 | 80.7% | — | ||
| Q4 24 | 85.3% | — | ||
| Q3 24 | 82.5% | — | ||
| Q2 24 | 82.0% | — | ||
| Q1 24 | 82.4% | — |
营业利润率LXPPTCT
| Q4 25 | 34.6% | -43.3% | ||
| Q3 25 | 50.4% | 1.4% | ||
| Q2 25 | 33.7% | -19.5% | ||
| Q1 25 | 21.8% | 82.5% | ||
| Q4 24 | — | -76.2% | ||
| Q3 24 | 7.9% | -27.7% | ||
| Q2 24 | 6.9% | -21.5% | ||
| Q1 24 | 1.0% | -21.6% |
净利率LXPPTCT
| Q4 25 | 33.2% | -82.0% | ||
| Q3 25 | 41.7% | 7.5% | ||
| Q2 25 | 33.2% | -36.3% | ||
| Q1 25 | 21.4% | 73.7% | ||
| Q4 24 | — | -30.9% | ||
| Q3 24 | 7.4% | -54.2% | ||
| Q2 24 | 6.3% | -53.1% | ||
| Q1 24 | -0.3% | -43.6% |
每股收益（稀释后）LXPPTCT
| Q4 25 | — | $-1.63 | ||
| Q3 25 | $0.12 | $0.20 | ||
| Q2 25 | $0.09 | $-0.83 | ||
| Q1 25 | $0.06 | $10.04 | ||
| Q4 24 | — | $-0.85 | ||
| Q3 24 | $0.02 | $-1.39 | ||
| Q2 24 | $0.01 | $-1.29 | ||
| Q1 24 | $-0.01 | $-1.20 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $170.4M | $1.9B |
| 总债务越低越好 | $1.4B | — |
| 股东权益账面价值 | $2.0B | $-205.3M |
| 总资产 | $3.5B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.66× | — |
8季度趋势，按日历期对齐
现金及短期投资LXPPTCT
| Q4 25 | $170.4M | $1.9B | ||
| Q3 25 | $229.7M | $1.7B | ||
| Q2 25 | $71.0M | $2.0B | ||
| Q1 25 | $70.9M | $2.0B | ||
| Q4 24 | $101.8M | $1.1B | ||
| Q3 24 | $55.0M | $1.0B | ||
| Q2 24 | $48.7M | $1.1B | ||
| Q1 24 | $293.8M | $884.8M |
总债务LXPPTCT
| Q4 25 | $1.4B | — | ||
| Q3 25 | $1.5B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益LXPPTCT
| Q4 25 | $2.0B | $-205.3M | ||
| Q3 25 | $2.1B | $-155.8M | ||
| Q2 25 | $2.1B | $-206.5M | ||
| Q1 25 | $2.1B | $-185.8M | ||
| Q4 24 | $2.1B | $-1.1B | ||
| Q3 24 | $2.1B | $-1.1B | ||
| Q2 24 | $2.1B | $-980.2M | ||
| Q1 24 | $2.2B | $-893.9M |
总资产LXPPTCT
| Q4 25 | $3.5B | $2.9B | ||
| Q3 25 | $3.7B | $2.6B | ||
| Q2 25 | $3.7B | $2.6B | ||
| Q1 25 | $3.8B | $2.7B | ||
| Q4 24 | $3.8B | $1.7B | ||
| Q3 24 | $3.9B | $1.8B | ||
| Q2 24 | $3.9B | $1.9B | ||
| Q1 24 | $4.2B | $1.8B |
负债/权益比LXPPTCT
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.72× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 0.73× | — | ||
| Q4 24 | 0.75× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $188.7M | $-34.3M |
| 自由现金流经营现金流 - 资本支出 | — | $-36.6M |
| 自由现金流率自由现金流/营收 | — | -22.3% |
| 资本支出强度资本支出/营收 | — | 1.4% |
| 现金转化率经营现金流/净利润 | 6.56× | — |
| 过去12个月自由现金流最近4个季度 | — | $702.3M |
8季度趋势，按日历期对齐
经营现金流LXPPTCT
| Q4 25 | $188.7M | $-34.3M | ||
| Q3 25 | $63.5M | $-66.3M | ||
| Q2 25 | $44.3M | $-58.3M | ||
| Q1 25 | $39.0M | $870.1M | ||
| Q4 24 | $211.2M | $-30.0M | ||
| Q3 24 | $64.6M | $-77.0M | ||
| Q2 24 | $38.5M | $-71.5M | ||
| Q1 24 | $38.9M | $70.8M |
自由现金流LXPPTCT
| Q4 25 | — | $-36.6M | ||
| Q3 25 | — | $-69.7M | ||
| Q2 25 | — | $-59.6M | ||
| Q1 25 | — | $868.4M | ||
| Q4 24 | — | $-33.8M | ||
| Q3 24 | — | $-77.5M | ||
| Q2 24 | — | $-78.8M | ||
| Q1 24 | — | $61.2M |
自由现金流率LXPPTCT
| Q4 25 | — | -22.3% | ||
| Q3 25 | — | -33.1% | ||
| Q2 25 | — | -33.3% | ||
| Q1 25 | — | 73.8% | ||
| Q4 24 | — | -15.8% | ||
| Q3 24 | — | -39.4% | ||
| Q2 24 | — | -42.2% | ||
| Q1 24 | — | 29.1% |
资本支出强度LXPPTCT
| Q4 25 | — | 1.4% | ||
| Q3 25 | — | 1.6% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 1.8% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 4.0% | ||
| Q1 24 | — | 4.6% |
现金转化率LXPPTCT
| Q4 25 | 6.56× | — | ||
| Q3 25 | 1.75× | -4.17× | ||
| Q2 25 | 1.52× | — | ||
| Q1 25 | 2.05× | 1.00× | ||
| Q4 24 | — | — | ||
| Q3 24 | 10.18× | — | ||
| Q2 24 | 7.09× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
